Literature DB >> 17560499

Infantile onset of hereditary spastic paraplegia poorly predicts the genotype.

Marcia A Blair1, Megan E Riddle, Jennifer F Wells, Brian A Breviu, Peter Hedera.   

Abstract

Age of symptom onset of hereditary spastic paraplegia varies from infancy to the eighth decade. Infantile onset of hereditary spastic paraplegia without a positive family history may cause difficulties in reaching the correct diagnosis and misdiagnosis as a diplegic form of cerebral palsy is particularly common. Infantile onset of hereditary spastic paraplegia caused by mutations in the spastin gene (SPAST) is very rare and previously was mostly associated with codominant mutations in this gene. We present a kindred with infantile onset of spastic paraplegia in three successive generations caused by confirmed de novo novel mutation 1537G>A (G471D) in SPAST. Several family members were previously diagnosed as having cerebral palsy. Infantile onset of hereditary spastic paraplegia may be caused by mutations in multiple genes, and this phenotype does not reliably predict the genotype. Pediatric neurologists need to be aware of relatively frequent de novo mutations in hereditary spastic paraplegia genes and a possibility that this condition presents in infancy without a positive family history.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560499     DOI: 10.1016/j.pediatrneurol.2007.02.003

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

Review 1.  Recent advances in the genetics of spastic paraplegias.

Authors:  Giovanni Stevanin; Merle Ruberg; Alexis Brice
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

Review 2.  Hereditary spastic paraplegia SPG4: what is known and not known about the disease.

Authors:  Joanna M Solowska; Peter W Baas
Journal:  Brain       Date:  2015-06-20       Impact factor: 13.501

3.  A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings.

Authors:  Alexandros A Polymeris; Alessandra Tessa; Katherine Anagnostopoulou; Anna Rubegni; Daniele Galatolo; Argirios Dinopoulos; Artemis D Gika; Sotiris Youroukos; Eleni Skouteli; Filippo M Santorelli; Roser Pons
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

4.  Genomic analysis identifies masqueraders of full-term cerebral palsy.

Authors:  Yusuke Takezawa; Atsuo Kikuchi; Kazuhiro Haginoya; Tetsuya Niihori; Yurika Numata-Uematsu; Takehiko Inui; Saeko Yamamura-Suzuki; Takuya Miyabayashi; Mai Anzai; Sato Suzuki-Muromoto; Yukimune Okubo; Wakaba Endo; Noriko Togashi; Yasuko Kobayashi; Akira Onuma; Ryo Funayama; Matsuyuki Shirota; Keiko Nakayama; Yoko Aoki; Shigeo Kure
Journal:  Ann Clin Transl Neurol       Date:  2018-03-26       Impact factor: 4.511

5.  Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China.

Authors:  En-Lin Dong; Chong Wang; Shuang Wu; Ying-Qian Lu; Xiao-Hong Lin; Hui-Zhen Su; Miao Zhao; Jin He; Li-Xiang Ma; Ning Wang; Wan-Jin Chen; Xiang Lin
Journal:  Mol Neurodegener       Date:  2018-07-06       Impact factor: 14.195

6.  A Japanese SPG4 Patient with a Confirmed De Novo Mutation of the SPAST Gene.

Authors:  Haitian Nan; Kensho Okamoto; Lihua Gao; Yuto Morishima; Yuta Ichinose; Kishin Koh; Masaki Hashiyada; Noboru Adachi; Yoshihisa Takiyama
Journal:  Intern Med       Date:  2020-06-09       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.